Abstract:Brain aging is characterized by a decrease in N‐methyl D‐aspartate mediated glutamate‐stimulated release of norepinephrine in the cerebral cortex. Proposed target sites for pharmacological restoration of deficits in norepinephrine release in the aging brain include blockade of alpha‐2 adrenergic receptors using mirtazapine or idazoxan, and targeting the norepinephrine reuptake inhibitor with the CNS stimulant methylphenidate. Aging affects virtually all organs of the body, but perhaps it has the most profound effects on the brain and its neurotransmitter systems, which influence a wide range of crucial functions, such as attention, focus, mood, neuroendocrine and autonomic functions, and sleep cycles. All of these essential functions, as well as fundamental cognitive processes such as memory, recall, and processing speed, utilize neuronal circuits that depend on neurotransmitter signaling between neurons. Glutamate (Glu), the main excitatory neurotransmitter in the CNS, is involved in most neuronal excitatory functions, including release of the neurotransmitter norepinephrine (NE). Previous studies from our lab demonstrated that the age‐associated decline in Glu‐stimulated NE release in rat cerebral cortex and hippocampus mediated by NMDA glutamate receptors, as well as deficits in dendritic spines, and cognitive functions are fully rescued by the CNS stimulant amphetamine. Here we further investigated Glu‐stimulated NE release in the cerebral cortex to identify additional novel target sites for restoration of Glu‐stimulated NE release. We found that blockade of alpha‐2 adrenergic receptors fully restores Glu‐stimulated NE release to the levels of young controls. In addition, we investigated the density and responsiveness of NMDA receptors as a potential underlying neuronal mechanism that could account for the observed age‐associated decline in Glu‐stimulated NE release. In the basal state of the receptor (no added glutamate and glycine) the density of NMDA receptors in the cortex from young and aged rats was similar. However, in contrast, in the presence of 10 μM added glutamate, which opens the receptor channel and increases the number of available [3H]‐MK‐801 binding sites within the channel, the density of [3H]‐MK‐801 binding sites was significantly less in the cortex from aged rats.

Reversal of aging-related emotional memory deficits by norepinephrine via regulating the stability of surface AMPA receptors.

Long-Term Potentiation is Impaired in Middle-Aged Rats: Regional Specificity and Reversal by Adenosine Receptor Antagonists

Restoration of norepinephrine release, cognitive performance, and dendritic spines by amphetamine in aged rat brain

Aging-Associated Formaldehyde-Induced Norepinephrine Deficiency Contributes to Age-Related Memory Decline

Emotion Enhances Learning Via Norepinephrine Regulation of AMPA-Receptor Trafficking

Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain

Paroxetine Ameliorates Prodromal Emotional Dysfunction and Late-Onset Memory Deficit in Alzheimer’s Disease Mice

A Distinct Role for Norepinephrine in Memory Retrieval

Dynamic Alteration of Neprilysin and Endothelin-Converting Enzyme in Age-Dependent Appswe/Ps1de9 Mouse Model of Alzheimer'S Disease

Aging disrupts locus coeruleus‐driven norepinephrine transmission in the prefrontal cortex: Implications for cognitive and motor decline

Electroacupuncture Attenuates Reference Memory Impairment Associated with Astrocytic NDRG2 Suppression in APP/PS1 Transgenic Mice.

Increasing NPYergic transmission in the hippocampus rescues aging-related deficits of long-term potentiation in the mouse dentate gyrus

The Role of N-Methyl-D-Aspartate Receptor in Alzheimer'S Disease

Delayed Noradrenergic Activation in the Dorsal Hippocampus Promotes the Long-Term Persistence of Extinguished Fear

Regulation of the NMDA receptor-mediated synaptic response by acetylcholinesterase inhibitors and its impairment in an animal model of Alzheimer's disease.

Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease.

Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats

Maintenance of superior learning and memory function in NR2B transgenic mice during ageing.

Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors

Astrocytic 5-HT1A receptor mediates age-dependent hippocampal LTD and fear memory extinction in male mice

Chronic alpha-linolenic acid treatment alleviates age-associated neuropathology: Roles of PERK/eIF2α signaling pathway